Records containing: Ulcerative Colitis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2018-01-19A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2018-01-17The Value of Virtual Chromoendoscopy With i-SCAN and Confocal Laser Endomicroscopy in the Assessement of Dysplasia on Patients With Inflammatory Bowel Disease
-
CLINICAL_TRIALS study record update · 2018-01-09Real-world Data Regarding Treatment of Ulcerative Colitis Patients With Golimumab
-
CLINICAL_TRIALS study record update · 2018-01-08Predicting Clinical Response to Golimumab With Mucosal Barrier Dysfunction
-
CLINICAL_TRIALS study record update · 2017-12-19A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-12-15Documentation of Colon Capsule Endoscopies in a National Observational Study [Dokumentation Von Kolonkapsel-Endoskopien im Rahmen Einer Bundesweiten Studie]
-
CLINICAL_TRIALS study record update · 2017-12-08Immunological Profiles in Inflammatory Bowel Disease
-
CLINICAL_TRIALS study record update · 2017-12-07Autoimmune Paradoxical Reactions in IBD Longitudinal Cohort - APRIL Cohort
-
CLINICAL_TRIALS study record update · 2017-10-27A Prospective Multi-centric Belgian Trial to Validate the Use of Golimumab Serum Level Analysis Using the Dried Blood Spot (DBS) Methodology
-
CLINICAL_TRIALS study record update · 2017-10-27Prevalence of Graves Disease in Patients With Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2017-10-26Non Genetic Factors in the Pathogenesis of Inflammatory Bowel Disease in Twins
-
CLINICAL_TRIALS study record update · 2017-10-26A Retrospective Multicentric Belgian Observational Trial to Evaluate the Successfulness of Adalimumab Dose Escalation and De-escalation in Patients With Moderate-to-severe Ulcerative Colitis Treated With Adalimumab
-
CLINICAL_TRIALS study record update · 2017-10-20Double-Blind, Randomized, Placebo-Controlled, Single Ascending and Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Target Engagement of BMS-986184 in Healthy Subjects and to Evaluate the Safety, Efficacy, Pharmacokinetics, Target Engagement, and Pharmacodynamics of BMS-986184 in Patients With Moderate to Severe Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2017-10-13Golimumab: A Phase 4, UK, Open Label, Single Arm Study on Its Utilization and Impact in Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2017-10-11A Randomized, Double-blind, Placebo-controlled, Multi-centre, Superiority Study Investigating the Efficacy and Safety of PENTASA Enema Compared With Placebo Enema for 4-Week Treatment in Chinese Patients With Left-sided Active Ulcerative Colitis (UC) Followed by a Maximal 28-Week Open-Label Extension Phase of PENTASA Enema and/or PENTASA Tablets
-
CLINICAL_TRIALS study record update · 2017-10-04Epidemiology of Ulcerative Colitis and Crohn's Disease in Non Jewish Israel Population
-
CLINICAL_TRIALS study record update · 2017-09-25A RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP STUDY TO EVALUATE THE SAFETY AND EFFICACY OF SWITCHING FROM INNOVATOR INFLIXIMAB TO BIOSIMILAR INFLIXIMAB COMPARED WITH CONTINUED TREATMENT WITH INNOVATOR INFLIXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS, SPONDYLOARTHRITIS, PSORIATIC ARTHRITIS, ULCERATIVE COLITIS, CROHN'S DISEASE AND CHRONIC PLAQUE PSORIASIS THE NOR-SWITCH STUDY
-
CLINICAL_TRIALS study record update · 2017-09-13The Impact of Anti-TNF Exposure on Vedolizumab Effectiveness: A Biomarker Study.
-
CLINICAL_TRIALS study record update · 2017-09-13Prospective Cohort of Ulcerative Colitis and Crohn's Disease Patients Undergoing Surgery to Identify Risk Factors for Post-Operative Infection I
-
CLINICAL_TRIALS study record update · 2017-09-06Fecal Microbiota Transplantation in Newly Diagnosed Patients With Ulcerative Colitis - a Double Blind, Placebo-Controlled Trial
-
CLINICAL_TRIALS study record update · 2017-08-25Manitoba Inflammatory Bowel Disease Cohort Study
-
CLINICAL_TRIALS study record update · 2017-08-24An Open Label, Dose Ranging, Exploratory Study to Evaluate the Safety, Tolerability, Compliance, Mechanism of Action and Efficacy of QBECO Site Specific Immunomodulation for the Induction of Clinical Response and Remission in Subjects With Moderate to Severe Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2017-07-28Amino Acids in Ileal Pouch-anal Anastomosis for Ulcerative Colitis: a Randomized, Assessor-blinded, Placebo-controlled Trial
-
CLINICAL_TRIALS study record update · 2017-07-19Self-Management Assistance for Recommended Treatment (SMART) Portal
-
CLINICAL_TRIALS study record update · 2017-07-07A Phase 2a, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Safety/Tolerability and Efficacy of TOP1288 200 mg Rectal Solution Once Daily for 4 Weeks in Symptomatic Ulcerative Colitis Patients With Moderate to Severe Disease Activity